Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma
NCT00276692
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
irinotecan hydrochloride
Sponsor
Children's Cancer and Leukaemia Group